French biotech firm Alderys has bought Eviagenics’ micro-organism based flavonoid production platform for an undisclosed sum. The deal will allow Alderys to commercialise the technology and Eviagenics to focus on its seaweed extracts venture.
A two-pronged approach to identifying bioactive plant compounds means that expected results can be rapidly confirmed, while the opportunity of unexpected discoveries still remains open, according to a France-based research services group.
Canadian life science company, Fytokem Products Inc., a developer
of therapeutic plant extracts and bioactive molecules, announced
that it has signed a product development and licensing agreement
with Lonza Inc., the US subsidiary...
